8.1K
Articles
237.5K
Citations
3.1
avg. Impact Factor
199
h-index

Most Cited Articles of Division of Hematology in 2012

TitleJournalYearCitations
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurementsJournal of Clinical Oncology2012582
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group studyLeukemia2012580
Clonal competition with alternating dominance in multiple myelomaBlood2012473
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificantBlood2012362
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myelomaBlood2012335
Concurrent validity of single-item measures of emotional exhaustion and depersonalization in burnout assessmentJournal of General Internal Medicine2012274
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNsJournal of Clinical Oncology2012252
IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphomaJournal of Clinical Investigation2012192
Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institutionClinical Journal of the American Society of Nephrology: CJASN2012191
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogeneticsBlood2012181
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and TreatmentBlood2012172
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)American Heart Journal2012167
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic valueBlood2012164
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomasBlood2012164
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group studyNeuro-Oncology2012160
Methodology for isolation, identification and characterization of microvesicles in peripheral bloodJournal of Immunological Methods2012154
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaHaematologica2012151
IMWG consensus on maintenance therapy in multiple myelomaBlood2012150
VEGF inhibition, hypertension, and renal toxicityCurrent Oncology Reports2012148
The high cost of cancer drugs and what we can do about itMayo Clinic Proceedings2012143
The clinical spectrum of Castleman's diseaseAmerican Journal of Hematology2012141
One thousand patients with primary myelofibrosis: the mayo clinic experienceMayo Clinic Proceedings2012137
Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancerInternational Journal of Radiation Oncology Biology Physics2012132
JAK inhibitors for myeloproliferative neoplasms: clarifying facts from mythsBlood2012129
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617FLeukemia2012129